Boston Family Office’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$455K Sell
48,992
-118
-0.2% -$1.16K 0.03% 230
2025
Q4
$343K Hold
49,110
0.02% 245
2025
Q3
$280K Sell
49,110
-600
-1% -$3.2K 0.02% 256
2025
Q2
$238K Sell
49,710
-30,501
-38% -$175K 0.02% 265
2025
Q1
$695K Sell
80,211
-8,655
-10% -$90.7K 0.05% 179
2024
Q4
$1.08M Sell
88,866
-4,435
-5% -$62K 0.07% 153
2024
Q3
$1.57M Sell
93,301
-596
-0.6% -$9.81K 0.11% 126
2024
Q2
$1.47M Buy
93,897
+2,246
+2% +$31.2K 0.11% 125
2024
Q1
$1.45M Sell
91,651
-5,930
-6% -$99.3K 0.1% 129
2023
Q4
$1.96M Sell
97,581
-4,565
-4% -$77.3K 0.15% 115
2023
Q3
$1.89M Sell
102,146
-2,110
-2% -$46K 0.16% 112
2023
Q2
$2.27M Buy
104,256
+3,610
+4% +$65.3K 0.17% 102
2023
Q1
$1.86M Sell
100,646
-201
-0.2% -$3.78K 0.15% 114
2022
Q4
$1.54M Sell
100,847
-7,239
-7% -$103K 0.13% 124
2022
Q3
$1.51M Sell
108,086
-15,226
-12% -$307K 0.13% 117
2022
Q2
$2.97M Sell
123,312
-9,014
-7% -$242K 0.25% 81
2022
Q1
$4.08M Hold
132,326
0.29% 75
2021
Q4
$6.01M Buy
132,326
+1,214
+0.9% +$51.9K 0.39% 68
2021
Q3
$5.69M Buy
131,112
+1,666
+1% +$72.5K 0.41% 67
2021
Q2
$5.96M Hold
129,446
0.43% 66
2021
Q1
$5.73M Sell
129,446
-480
-0.4% -$20.1K 0.43% 62
2020
Q4
$5.15M Sell
129,926
-266
-0.2% -$9.89K 0.4% 66
2020
Q3
$5.09M Buy
130,192
+1,200
+0.9% +$45.9K 0.46% 56
2020
Q2
$5M Buy
128,992
+2,548
+2% +$86.1K 0.49% 56
2020
Q1
$4.24M Buy
126,444
+1,632
+1% +$53.6K 0.5% 59
2019
Q4
$4.07M Buy
124,812
+3,278
+3% +$108K 0.39% 72
2019
Q3
$4.14M Buy
121,534
+1,534
+1% +$53.1K 0.43% 67
2019
Q2
$3.73M Buy
120,000
+3,242
+3% +$95.5K 0.39% 74
2019
Q1
$3.35M Buy
116,758
+6,726
+6% +$203K 0.36% 80
2018
Q4
$3.14M Buy
110,032
+18,444
+20% +$577K 0.39% 73
2018
Q3
$3.28M Sell
91,588
-1,262
-1% -$53.8K 0.35% 87
2018
Q2
$3.72M Sell
92,850
-738
-0.8% -$27.2K 0.42% 73
2018
Q1
$3.13M Sell
93,588
-41,953
-31% -$1.26M 0.36% 83
2017
Q4
$3.13M Buy
135,541
+49,866
+58% +$1.51M 0.34% 88
2017
Q3
$2.49M Hold
85,675
0.28% 98
2017
Q2
$2.22M Sell
85,675
-40
-0% -$958 0.26% 100
2017
Q1
$2.11M Sell
85,715
-536
-0.6% -$13.1K 0.26% 101
2016
Q4
$2.13M Sell
86,251
-466
-0.5% -$10.3K 0.28% 99
2016
Q3
$1.82M Sell
86,717
-227
-0.3% -$4.86K 0.24% 110
2016
Q2
$1.83M Hold
86,944
0.24% 109
2016
Q1
$1.64M Hold
86,944
0.22% 118
2015
Q4
$1.84M Sell
86,944
-67
-0.1% -$1.37K 0.25% 111
2015
Q3
$1.47M Hold
87,011
0.2% 122
2015
Q2
$1.55M Buy
87,011
+134
+0.2% +$2.32K 0.19% 120
2015
Q1
$1.52M Sell
86,877
-9,494
-10% -$174K 0.19% 119
2014
Q4
$1.79M Hold
96,371
0.22% 113
2014
Q3
$1.43M Buy
96,371
+667
+0.7% +$10.5K 0.18% 123
2014
Q2
$1.45M Sell
95,704
-720
-0.7% -$10.7K 0.18% 120
2014
Q1
$1.63M Sell
96,424
-307
-0.3% -$5.02K 0.22% 114
2013
Q4
$1.66M Sell
96,731
-1,429
-1% -$24.8K 0.22% 110
2013
Q3
$1.49M Hold
98,160
0.21% 114
2013
Q2
$1.36M Buy
+98,160
New +$1.3M 0.21% 112

Other funds holding NEOG

Boston Family Office's NEOG Position: Q1 2026 in Review

Boston Family Office reduced its Neogen (NEOG) stake by 0.24% in Q1 2026, selling an estimated $1.16K and leaving 48,992 shares worth $455K. The position accounts for 0.03% of the portfolio, ranked #230.

Boston Family Office first reported a position in NEOG in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.01M in Q4 2021. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Boston Family Office held 48,992 shares of Neogen worth $455K as of Q1 2026.
  • Boston Family Office sold 118 Neogen shares in Q1 2026, an estimated $1.16K.
  • Neogen made up 0.03% of Boston Family Office's portfolio in Q1 2026, its #230 holding.
  • Boston Family Office first reported a position in Neogen in Q2 2013 and has held it in 52 quarters since.
  • Boston Family Office's Neogen position peaked at $6.01M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.